← All comparisons
Head-to-head · FAERS comparison

Evolocumab vs Ezetimibe: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

EvolocumabEzetimibe
Drug classPCSK9 InhibitorDietary Cholesterol Absorption Inhibitor
Brand namesRepatha–
FAERS reports161,20974,507
Serious17%65%
Death outcome2,0354,305
Boxed warningNoNo

Signals both drugs share

ReactionEvolocumabEzetimibeLabel screen (A / B)
Type iia hyperlipidaemia69 · PRR 56.765 · PRR 113.1Not in label — unassessed / Likely indication confounding
Vascular stent stenosis44 · PRR 15.346 · PRR 34.9Not in label — unassessed / Not in label — unassessed

Labeled signals distinctive to Evolocumab

Labeled signals distinctive to Ezetimibe

  • Myopathy — n=431, PRR 14.7 Labeled adverse reaction
  • Dyslipidaemia — n=221, PRR 12.7 Labeled adverse reaction

Common questions

Which has more reported side effects, Evolocumab or Ezetimibe?

Evolocumab has 161,209 FAERS reports and Ezetimibe 74,507. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (17% vs 65%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Evolocumab and Ezetimibe share?

Both drugs carry disproportionality signals for type iia hyperlipidaemia, vascular stent stenosis. Shared signals often reflect a shared drug class or the condition both are used for.

Is Evolocumab or Ezetimibe safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.